Company intelligence / Profile preview

Yunnan Jingxin Biotechnology

Kunming, Yunnan, China

Ownership: Private
Development stage: Other

Overview

Yunnan Jingxin Biotechnology is a Chinese biotechnology company focused on the industrial hemp industry, specifically the cultivation, processing, and extraction of cannabinoids like cannabidiol (CBD). As a subsidiary of Zhejiang Jingxin Pharmaceutical, the company leverages pharmaceutical-grade standards to develop high-purity hemp-derived ingredients for medical and health applications. Its operations are centered in Yunnan Province, which is a primary hub for legal industrial hemp in China. The company aims to integrate hemp resources with pharmaceutical research to explore therapeutic uses in areas such as pain management and neurological health.

Therapeutic areas: ImmunologyNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Yunnan Jingxin Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yunnan Jingxin Biotechnology.

Explore the full profile